D&A
Flow – sum over the period · $M
Q2 2026
6.6$M
All values (42)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 6.6 | reported |
| Q1 2026 | 6.4 | reported |
| Q4 2025 | 6.7 | derived |
| Q3 2025 | 7.3 | reported |
| Q2 2025 | 8.3 | reported |
| Q1 2025 | 8.9 | reported |
| Q4 2024 | 8.8 | derived |
| Q3 2024 | 9.0 | reported |
| Q2 2024 | 9.3 | reported |
| Q1 2024 | 9.8 | reported |
| Q4 2023 | 10.4 | derived |
| Q3 2023 | 10.8 | derived |
| Q2 2023 | 11.3 | derived |
| Q1 2023 | 11.6 | reported |
| Q4 2022 | 11.7 | derived |
| Q3 2022 | 11.4 | derived |
| Q2 2022 | 11.9 | derived |
| Q1 2022 | 11.9 | reported |
| Q4 2021 | 12.3 | derived |
| Q3 2021 | 12.0 | derived |
| Q2 2021 | 12.0 | derived |
| Q1 2021 | 11.6 | reported |
| Q4 2020 | 11.9 | derived |
| Q3 2020 | 11.6 | derived |
| Q2 2020 | 11.6 | derived |
| Q1 2020 | 11.2 | reported |
| Q4 2019 | 12.0 | derived |
| Q3 2019 | 11.4 | derived |
| Q2 2019 | 11.3 | derived |
| Q1 2019 | 11.6 | reported |
| Q4 2018 | 11.9 | derived |
| Q3 2018 | 12.3 | derived |
| Q2 2018 | 12.1 | derived |
| Q1 2018 | 12.1 | reported |
| Q4 2017 | 12.2 | derived |
| Q3 2017 | 12.5 | derived |
| Q2 2017 | 12.1 | derived |
| Q1 2017 | 13.1 | reported |
| Q4 2016 | 14.1 | derived |
| Q3 2016 | 14.7 | derived |
| Q2 2016 | 14.6 | derived |
| Q1 2016 | 14.9 | reported |
CSV with all sources · Technical ID: dna
More metrics for VeriSign
Income statement
Balance sheet
Debt and interest
Sources & calculation
- Value
- $7.0M
- Period
- Q2 2026, ended Jun 30, 2026 · quarterly value (3 months, not cumulative)
- Source
- 10-Q, filed Jul 23, 2026 · 0001014473-26-000028
- Location
- us-gaap:DepreciationAndAmortization
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $7.0M | Jul 23, 2026 | 10-Q 0001014473-26-000028 | reported · confidence 1. · current |